Preceding the 64th ASH Annual Meeting and Exposition
Sign up to access on-demand presentations and slidesets on the latest hematology research. Get expert commentary on topics ranging from AL amyloidosis to B-cell lymphomas. Sign up to claim your free CME/CE credits.
New Hematology Paradigms
Sign up for on-demand viewing and slideset downloads.
Program Director
Member, Memorial Sloan Kettering Cancer Center
Attending Physician, Memorial Hospital
Professor of Medicine, Weill Cornell Medical College
New York, New York
Assistant Professor
Department of Hematology/
Oncology
Emory University, Winship Cancer Institute
The Emory Clinic
Atlanta, Georgia
Associate Professor
Department of Medicine, Division of Medical Oncology
Medical Oncologist
Department of Medical Oncology
British Columbia Cancer Agency
Vancouver, British Columbia, Canada
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Designation of Credit
CCO designates live activities in these sessions account for 1.5 - 2.0 AMA PRA Category 1 Credits™ per event. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Clinical Care Options, LLC. is committed to providing a safe and healthy environment for all our learners. Our decisions and preventive measures are guided by the requirements and recommendations of the CDC alongside federal, state, and local health authorities. We work with each program venue to implement preventive measures to reduce the potential spread of COVID-19. In addition, in accordance with The American Society of Hematology’s (ASH) COVID-19 protocols, all in-person learners will be asked to wear a mask and present their ASH conference badge -OR- proof of vaccination* AND government-issued ID to gain admittance to Acute Lymphoblastic Leukemia Data and Case Discussion on the Use of Asparaginase Therapy in Young and Older Adults.
For more information on ASH’s vaccination and mask requirements, please visit: ASH’S website
*If you do not have your vaccination record card, find other ways to verify you have been vaccinated.
Friday Satellite Symposium on “Advances in the Treatment of T-Cell Lymphomas: A Forum for Data and Case Discussion”, preceding the 64th ASH Annual Meeting and Exposition.
Provided by Clinical Care Options, LLC
Supported by educational grants from
Lilly
Novartis Pharmaceuticals Corporation
Sanofi Genzyme